GSK-J4

英文名： GSK-J4

别名： GSK J4 抑制剂;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯;GSK-J4;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-beta-丙氨酸乙酯 GSK J4 抑制剂;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯;GSK-J4;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-beta-丙氨酸乙酯展开

CAS No. : 1373423-53-0

分子式 : C₂₄H₂₇N₅O₂

分子量 : 417.5

大包装询价? 收藏产品

中文名称	GSK-J4
中文别名	GSK J4 抑制剂;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯;GSK-J4;N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-beta-丙氨酸乙酯
英文名称	GSK-J4
英文别名	GSK J4;ethyl 3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate;GSK J4 HCl;Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate;GSK-J4;ETHYL 3-{[2-(PYRIDIN-2-YL)-6-(1,2,4,5-TETRAHYDRO-3-BENZAZEPIN-3-YL)PYRIMIDIN-4-YL]AMINO}PROPANOATE;DA-63950;EN300-126002;AKOS024458241;Ethyl-3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate; GSK J4;GSK-J4, >=98% (HPLC);DTXSID201025774;CHEBI:95077;GSK J4 hydrochloride;SCHEMBL14931829;BDBM50483927;BRD-K98203492-001-01-1;A857328;ethyl 3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoate;N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester;1373423-53-0;HB1407;BG162626;ethyl 3-(6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoate;GSKJ4;MFCD22683852;SB19351;J-007003;BCP08261;CS-3986;AC-32705;Q27077925;N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanin e ethyl ester;HY-15648B;CHEMBL3183531;Z1543021064;GTPL8979;Histone Lysine Demethylase Inhibitor VIII;AS-78162;GSK-J1 Pro-Drug;BRD-K98203492-003-04-1;GSKJ4 compound
CAS No.	1373423-53-0
分子式	C₂₄H₂₇N₅O₂
分子量	417.50